Lichen Sclerosus in Cancer Patients
Breast cancer was the most common primary tumor among patients in this study. The most common cancer therapy regimen was hormonal therapy. Most patients required an escalation in therapy to manage their LS. For patients undergoing cancer treatment, concomitant LS management can present unique challenges due to the biological mechanism of some anticancer therapies and the pathophysiology of LS. There is limited data to guide treatment of LS for this population. Some of the patients included in this analysis had progression of LS and recurrence of cancer while undergoing management of both conditions, necessitating close follow-up.
Authors
- Mario E. Lacouture (ORCID: https://orcid.org/0000-0002-4818-3710)
- Alina Markova (ORCID: https://orcid.org/0000-0002-2427-3199)
- Sarah Noor (ORCID: https://orcid.org/0009-0005-5411-7145)
- Amaris Geisler (ORCID: https://orcid.org/0000-0001-7376-3779)
- Deborah J. Goldfrank
- Kara Long Roche (ORCID: https://orcid.org/0000-0003-0342-2922)
- S. K. Jain (ORCID: https://orcid.org/0009-0006-5170-7593)
Institutions
- Northwell Health (US)
- Memorial Sloan Kettering Cancer Center (US)
- Emory University (US)
- Cornell University (US)
- NYU Langone Health (US)
- Louisiana State University Health Sciences Center Shreveport (US)
Publication Details
- Journal
- Journal of Lower Genital Tract Disease
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1097/lgt.0000000000000870
- Primary Topic
- Genital Health and Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Memorial Sloan-Kettering Cancer Center